Dear AuntMinnie Member,
The growth of the PET market in recent years has been impressive, with booming scanner sales and fast-growing procedure volume. The arrival of PET/CT systems promises new clinical indications that could expand the modality's reach even further.
But not all is rosy in the world of PET. A recent wave of scanner purchases has left many areas with more capacity than the market can support; some sites are doing as few as three patients a day. And recent news on reimbursement has been mixed, with U.S. regulators proposing to pay for new applications like Alzheimer's imaging, while proposing sharply lower rates for all PET procedures.
The PET market is the subject of a new article we're featuring in our Molecular Imaging Digital Community. Authored by imaging industry consultant Marvin Burns of Bio-Tech Systems, the story explores the challenges and opportunities imaging providers and vendors are facing as the modality matures.
You'll also find statistics on PET's growth, and an analysis of the potential impact of reimbursement for Alzheimer's disease. Finally, Burns offers tips on what PET vendors and FDG suppliers can do to put the spark back into the modality. Check it out in our Molecular Imaging Digital Community, at molecular.auntminnie.com.
